The MUMPS: McGill University Medical Podcast Series-logo

The MUMPS: McGill University Medical Podcast Series

Science Podcasts >

Hey there, and welcome to The MUMPS: The McGill University Medical Podcast Series! This is a podcast geared towards aspiring, training or practicing health care professionals who are looking to keep up to date with the latest medical research going on at McGill and its affiliated institutions. Tune in bi-monthly as your hosts Russ and Eric chat with basic science and clinical researchers behind some of McGill University's most current, influential and thought-provoking medical research.

Hey there, and welcome to The MUMPS: The McGill University Medical Podcast Series! This is a podcast geared towards aspiring, training or practicing health care professionals who are looking to keep up to date with the latest medical research going on at McGill and its affiliated institutions. Tune in bi-monthly as your hosts Russ and Eric chat with basic science and clinical researchers behind some of McGill University's most current, influential and thought-provoking medical research.
More Information

Location:

Canada

Description:

Hey there, and welcome to The MUMPS: The McGill University Medical Podcast Series! This is a podcast geared towards aspiring, training or practicing health care professionals who are looking to keep up to date with the latest medical research going on at McGill and its affiliated institutions. Tune in bi-monthly as your hosts Russ and Eric chat with basic science and clinical researchers behind some of McGill University's most current, influential and thought-provoking medical research.

Language:

English

Contact:

4384925671


Episodes

Episode 1 - Paul Savage - A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer

2/24/2018
More
Paul Savage is an MD-PhD student in the lab of Dr. Morag Park at the Goodman Cancer Research Centre in Montreal, Canada. In this episode, we discuss his latest article published in the October 2017 edition of Cell Reports. Using a patient-derived xenograft model to screen triple negative breast cancer (TNBC) tumours for susceptibility to targeted therapies, he and his colleagues identified an exceptional responder to treatment with the epidermal growth factor receptor (EGFR) inhibitor...

Duration:00:08:00

Try Premium for 30 days

Live games for all NFL, MLB, NBA, & NHL teams
Commercial-Free Music
No Display Ads